2009 - Review: Pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality

Johnstone, Jennie
May 2009
ACP Journal Club;5/19/2009, Vol. 150 Issue 5, p2
Academic Journal
The article cites several studies to find out whether pneumococcal vaccination is effective for various clinical outcomes in adults. The studies compared pneumococcal polysaccharide vaccine with placebo, other vaccines, or no intervention control. Meta-analysis of the studies showed that pneumococcal vaccination did not differ from control for definitive pneumococcal pneumonia and that the pneumococcal vaccination group had fewer cases of presumptive pneumococcal pneumonia.


Related Articles

  • Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. Maruyama, Takaya; Taguchi, Osamu; Niederman, Michael S.; Morser, John; Kobayashi, Hiroyasu; Kobayashi, Tetsu; D'Alessandro-Gabazza, Corina; Nakayama, Sei; Nishikubo, Kimiaki; Noguchi, Takashi; Takei, Yoshiyuki; Gabazza, Esteban C. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/13/2010, Vol. 340 Issue 7746, p579 

    The article discusses a double blind, randomised and placebo controlled trial, which investigated the efficacy of the 3-valent pneumococcal polysaccharide vaccine in preventing pneumonia and improving survival in nursing home residents in Japan. The trial involved 1,006 nursing home residents in...

  • Population-Based Results for Pneumococcal Conjugate Vaccine. Zepf, Bill // American Family Physician;1/1/2004, Vol. 69 Issue 1, p193 

    Presents a study which examined the impact of the introduction of protein-polysaccharide conjugate vaccine in reducing the incidence of invasive pneumococcal disease in young children. Analysis of data; Baseline rate of invasive pneumococcal disease among children younger than two years;...

  • Infants too young to receive pneumococcal conjugate vaccine benefit from herd immunity. Carter, R. J. F. // Thorax;Jul2006, Vol. 61 Issue 7, p610 

    The article reports that infants too young to receive a heptavalent pneumococcal conjugate vaccine (PCV7) are benefiting from herd immunity. Evidence has shown that the rate of invasive pneumococcal disease (IPD) among children younger than 2 years has reduced since the introduction of PCV7....

  • An evaluation of emerging vaccines for childhood pneumococcal pneumonia. Webster, Julia; Theodoratou, Evropi; Nair, Harish; Seong, Ang Choon; Zgaga, Lina; Huda, Tanvir; Johnson, Hope L.; Madhi, Shabir; Rubens, Craig; Zhang, Jian Shayne F.; Arifeen, Shams El; Krause, Ryoko; Jacobs, Troy A.; Brooks, Abdullah W.; Campbell, Harry; Rudan, Igor // BMC Public Health;2011 Supplement 3, Vol. 11 Issue Suppl 3, p1 

    Background: Pneumonia is the leading cause of child mortality worldwide. Streptococcus pneumoniae (SP) or pneumococcus is estimated to cause 821,000 child deaths each year. It has over 90 serotypes, of which 7 to 13 serotypes are included in current formulations of pneumococcal conjugate...

  • Does treatment with donepezil improve memory for patients with mild cognitive impairment? Stiles, Melissa M.; Martin, Sandra // Journal of Family Practice;May2006, Vol. 55 Issue 5, p435 

    The article presents information on the studies conducted to determine if treatment for patients with mild cognitive impairment with Donepezil can improve the patients' memories. Donepezil does not improve the patients' memory with the impairment is an evidence based answer, and its cost, the...

  • Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine Administered According to 4 Different Primary Immunization Schedules in Infants. Spijkerman, Judith; Veenhoven, Reinier H.; Wijmenga-Monsuur, Alienke J.; Elberse, Karin E. M.; van Gageldonk, Pieter G. M.; Knol, Miriam J.; de Melker, Hester E.; Sanders, Elisabeth A. M.; Schouls, Leo M.; Berbers, Guy A. M. // JAMA: Journal of the American Medical Association;9/4/2013, Vol. 310 Issue 9, p930 

    IMPORTANCE Immunization schedules with pneumococcal conjugate vaccine (PCV) differ among countries regarding the number of doses, age at vaccinations, and interval between doses. OBJECTIVE To assess the optimal primary vaccination schedule by comparing immunogenicity of 13-valent PCV (PCV13) in...

  • THE PLACEBO: A READER. Lott, Rob // Health Affairs;Mar2014, Vol. 33 Issue 3, p518 

    No abstract available.

  • Ethics of the use of placebos in clinical research: a proposal for decision-making algorithms. Guerreiro Fregnani, José Humberto Tavares; Carvalho, André Lopes; Paranhos, Flávio Rocha Lima; de Souza Viana, Luciano; Serrano, Sérgio Vicente; Cárcano, Flávio; Ferreira, João Fernando Monteiro; Zier, Sandra Solci; Gontijo, Pollyana Anício Magalhães; Stefanoff, Cláudio Gustavo; França, Paulo Henrique Condeixa; de Almeida Bendati, Maria Mercedes; Marodin, Gabriela; de Almeida Venâncio, Jorge Alves // Revista Bioetica;2015, Vol. 23 Issue 3, p456 

    The use of placebos in clinical research has been a matter of considerable debate in recent years, notably when the World Medical Association published, in 2002, a note of clarification for paragraph 29 of the Helsinki Declaration. Brazil is known for its strong opposition to the flexible use of...

  • Antigens from Leishmania amastigotes induced clinical remission of psoriasis. O'Daly, J. A.; Lezama, R.; Rodriguez, P. J.; Silva, E.; Indriago, N. R.; Peña, G.; Colorado, I.; Gleason, J.; Rodríguez, B.; Acuña, L.; Ovalles, T. // Archives of Dermatological Research;Jan2009, Vol. 301 Issue 1, p1 

    While injecting volunteers in Venezuela with a vaccine for prevention of leishmaniasis, we observed 100% clinical remission of a psoriatic lesion in one subject. Subsequently, the vaccine (AS100) was evaluated in psoriatic patients with an open label, single center study. The study was conducted...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics